X0609 4 2025-07-31 0 0001826667 TriSalus Life Sciences, Inc. TLSI 0001251956 MATLIN DAVID J false 6272 W. 91ST AVENUE WESTMINSTER CO 80031 1 0 0 0 0 Common Stock 2025-07-31 4 C 0 330000 0 A 1271944 D Series A Preferred Stock 4 2025-07-31 4 C 0 100000 0 D Common Stock 330000 0 D Represents shares received upon conversion of the Series A Preferred Stock (the "Preferred Stock") reported in Table II. Represents conversion price pursuant to an offer (the "Offer") the Company commenced on June 23, 2025, under which all holders of Preferred Stock could exchange their shares of Preferred Stock for Common Stock equal to the sum of the liquidation preference per share price of $10.00 and all accrued and unpaid dividends per share outstanding through August 10, 2027, divided by a $4.00 conversion price per share. On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer. /s/ Mary Szela, Attorney-in-Fact 2026-04-01